Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$184.17 USD
-0.31 (-0.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $184.28 +0.11 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $0.85 | 5.12% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.50 per share. This reflects a positive earnings surprise of 72.00%. Look out for KRYS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.85 per share, reflecting a year-over-year increase of 226.87%.
Earnings History
Price & Consensus
Zacks News for KRYS
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services